Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A STOLK

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
Health and Quality of Life Outcomes|November 30, 2010
Mapping onto Eq-5 D for patients in poor healthMatthijs M Versteegh, Donna Rowen, John E Brazier, et al.
Health Economics|December 20, 2018
Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experimentsMarcel F Jonker, Bas Donkers, Esther de Bekker-Grob, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Time trade-off: one methodology, different methodsArthur E Attema, Yvette Edelaar-Peeters, Matthijs M Versteegh, et al.
Magnetic Resonance in Medicine|July 1, 1987
Effects of age on apparent 31P spin-lattice relaxation times of rat brain phosphatesJ A Stolk, J I Olsen, D W Alderman, et al.
Social Science & Medicine (1982)|November 4, 2004
Acceptability of less than perfect health statesWerner B F Brouwer, N Job A van Exel, Elly A Stolk
Molecular and Cellular Biology|July 1, 1993
Human SR proteins and isolation of a cDNA encoding SRp75A M Zahler, K M Neugebauer, J A Stolk, et al.
Genes & Development|May 1, 1992
SR proteins: a conserved family of pre-mRNA splicing factorsA M Zahler, W S Lane, J A Stolk, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Introducing the composite time trade-off: a test of feasibility and face validityBas M F Janssen, Mark Oppe, Matthijs M Versteegh, et al.
Parasitology Today (Personal Ed.)|June 20, 2000
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infectionA P Plaisier, W A Stolk, G J van Oortmarssen, et al.
Parasites & Vectors|September 15, 2016
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicatorsPurushothaman Jambulingam, Swaminathan Subramanian, S J de Vlas, et al.
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
Health and Quality of Life Outcomes|November 30, 2010
Mapping onto Eq-5 D for patients in poor healthMatthijs M Versteegh, Donna Rowen, John E Brazier, et al.
Health Economics|December 20, 2018
Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experimentsMarcel F Jonker, Bas Donkers, Esther de Bekker-Grob, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Time trade-off: one methodology, different methodsArthur E Attema, Yvette Edelaar-Peeters, Matthijs M Versteegh, et al.
Magnetic Resonance in Medicine|July 1, 1987
Effects of age on apparent 31P spin-lattice relaxation times of rat brain phosphatesJ A Stolk, J I Olsen, D W Alderman, et al.
Social Science & Medicine (1982)|November 4, 2004
Acceptability of less than perfect health statesWerner B F Brouwer, N Job A van Exel, Elly A Stolk
Molecular and Cellular Biology|July 1, 1993
Human SR proteins and isolation of a cDNA encoding SRp75A M Zahler, K M Neugebauer, J A Stolk, et al.
Genes & Development|May 1, 1992
SR proteins: a conserved family of pre-mRNA splicing factorsA M Zahler, W S Lane, J A Stolk, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Introducing the composite time trade-off: a test of feasibility and face validityBas M F Janssen, Mark Oppe, Matthijs M Versteegh, et al.
Parasitology Today (Personal Ed.)|June 20, 2000
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infectionA P Plaisier, W A Stolk, G J van Oortmarssen, et al.
Parasites & Vectors|September 15, 2016
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicatorsPurushothaman Jambulingam, Swaminathan Subramanian, S J de Vlas, et al.
Pageof 17